A Phase II Clinical Trial on the Efficacy and Safety of TQC3721 Inhalation Powder

Clinical trial NCT07252908 · COMPLETED

Trial details

NCT number: NCT07252908
Sponsor: Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Pulmonary Disease, Chronic Obstructive

Start date: 2025-12-22
Primary completion: 2026-04-28
Enrollment: 195

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.